Follow-up of chronic paediatric hepatitis C virus in a low-/middle-income country.

Mortada H F El-ShabrawiSherif BaroudyFetouh HassaninAhmed Saed BehairyMostafa YakootAyaat Ahmed

Published in: Acta paediatrica (Oslo, Norway : 1992) (2020)

In our cohort, SOF/LED therapy and SOF/DCV therapy were extremely safe and effective with 100% SVR and negligible short-term side effects. IFN/RBV therapy was much less effective (SVR 57.1%) and accompanied with short-term side effects. Fibrosis might stop and even regress with successful treatment.

Keyphrases

hepatitis c virus
emergency department
intensive care unit
physical activity
human immunodeficiency virus
mental health
stem cells
mesenchymal stem cells
cell therapy